A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea | |
Zhang, Fengchun; Bae, Sang-Cheol; Bass, Damon; Chu, Myron; Egginton, Sally; Gordon, David; Roth, David A.; Zheng, Jie; Tanaka, Yoshiya | |
2018 | |
卷号 | 77期号:3页码:355-363 |
关键词 | Disease Activity Systemic Lupus Erythematosus Treatment |
ISSN号 | 0003-4967 |
DOI | 10.1136/annrheumdis-2017-211631 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6361382 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Zhang, Fengchun,Bae, Sang-Cheol,Bass, Damon,et al. A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea[J],2018,77(3):355-363. |
APA | Zhang, Fengchun.,Bae, Sang-Cheol.,Bass, Damon.,Chu, Myron.,Egginton, Sally.,...&Tanaka, Yoshiya.(2018).A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea.,77(3),355-363. |
MLA | Zhang, Fengchun,et al."A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea".77.3(2018):355-363. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论